Setting up a harmonised methodology to promote uptake of early feasibility studies for clinical and innovation excellence in the European Union

This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives. It details which entities can apply, where projects can be implemented, and the strategic goals the program aims to achieve, focusing on advancing health technology innovation and clinical research within the EU.

This section details the types of projects and thematic areas eligible for funding under the Early Feasibility Studies program. It specifies the industries and research fields supported, clarifies that the program is designed for early to experimental stages of development, and outlines the types of costs covered, although specific cost details are largely referenced to external documents.

This section describes the nature of financial support available through the program, specifically highlighting that funding is provided as grants and specifying the maximum amount available per project. It also indicates the project duration, where applicable.

This section outlines the key conditions and requirements for participation in the Early Feasibility Studies program, covering aspects from application submission and consortium formation to specific legal and operational provisions.

This section details the structured process for applying to the Early Feasibility Studies program, including the multi-stage submission flow, required documentation, and how applications are evaluated and decisions are communicated.

This section identifies the foundational legal and official documents that establish and govern the Early Feasibility Studies funding program, along with other key regulations and policies that influence its implementation.